Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Looking Backward to Go Forward
GSK’s Anne Phillips tells NGP why drug discovery should follow from the patient’s needs, rather than the other way around.
No Comments
Standing out from the Crowd
Mike Cola and Sylvie Gregoire of Shire Pharmaceuticals explain why being different is increasingly important in the dark days of economic recession.
No Comments
Incentive Compensation Plan Diagnosis in the Pharmaceutical Industry
As pharmaceutical companies step up their focus on retaining key sales staff, they are considering ways to leverage variable compensation as a strategic tool to maximize ROI in top talent.
No Comments
Checkmate
Generic drugs, having long been minor players in the pharmaceutical marketplace, appear to be gaining a strategic advantage. Is this end game for branded products?
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.